The prognosis of elderly patients with hepatocellular carcinoma: A multi-center 19-year experience in Japan.

ABSTRACT:

Aims

This retrospective study compared the survival between elderly and non-elderly patients.

Methods

A total of 5545 treatment-naive patients with hepatocellular carcinoma (HCC) who visited 7 different hospitals from January 2000 to December 2018 were included. Patients ≥80 years old were defined as elderly patients. We divided the patients into three groups based on the timing of the initial treatment: Early, middle, and late periods defined as 2000 to 2005, 2006 to 2012, and 2013 to 2018, respectively.

Results

There were 132 (8.9%), 405 (17.5%), and 388 (22.2%) elderly patients in the early, middle, and late period, respectively, showing a significant increase over time (p < 0.001). In both elderly and non-elderly patients, the median albumin-bilirubin score signif

SUBMITTER: Hatanaka T 

PROVIDER: S-EPMC9844645 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature